Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
Aigner, RM; Fueger, GF; Lax, S.
A case of parathyroid carcinoma visualized on Tc-99m-sestamibi scintigraphy.
Nuklearmedizin. 1997; 36(7):256-258
Doi: 10.1055/s-0038-1629843
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
- Aigner Reingard
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Recent studies indicate that Tc-99m-Sestamibi (MIBI, DuPont Pharma) is a useful tracer for detecting parathyroid adenomas. We present a patient with focal Tc-99m-MIBI uptake in parathyroid carcinoma which has only been described once before (1). Tc-99m-MIBI scintigraphy may be considered for diagnosing pathological parathyroid tissue. But presently the histopathological examination only allows the differentiation between adenoma and carcinoma.
- Find related publications in this database (using NLM MeSH Indexing)
- Aged -
- Diagnosis, Differential -
- Female -
- Humans -
- Parathyroid Neoplasms - pathology Parathyroid Neoplasms - radionuclide imaging Parathyroid Neoplasms - surgery Parathyroid Neoplasms - ultrasonography
- Radiopharmaceuticals - diagnostic use Radiopharmaceuticals - pharmacokinetics
- Technetium Tc 99m Sestamibi - diagnostic use Technetium Tc 99m Sestamibi - pharmacokinetics
- Thyroid Gland - ultrasonography
- Find related publications in this database (Keywords)
- Tc-99m-Sestamibi
- Parathyroid Carcinoma
- Parathyroid Adenoma